Register for upcoming webinars or watch replays of past webinars hosted by ProPharma's vast pool of experts from all over the globe.
July 29, 2025
Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert guidance from our experts. Beginning August 2025, FDA inspections at non-U.S. manufacturing sites will...
July 29, 2025
Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert guidance from our experts. Beginning August 2025, FDA inspections at non-U.S. manufacturing sites will occur without prior notice, requiring continuous inspection readiness. This webinar, led by ProPharma’s inspection readiness experts, will explore what it means to be truly inspection ready and highlight common issues found during FDA inspections—helping your organization stay compliant and prepared.
July 22, 2025
Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand knowledge of the Agency’s review process, he’ll walk through the most common deficiencies that lead to review delays and discuss how to avoid them. From strategic labeling decisions tied to patents and exclusivities to submission formatting and data integrity, this session will provide practical guidance to help applicants craft a more efficient, quality, and approvable ANDA.
July 10, 2025
This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and strategies for successful market access—from initial authorization to product launch. Ideal for regulatory, PV, clinical, and commercial professionals.
June 03, 2025
This webinar will explore the strategies and best practices for establishing a cost-effective global Medical Information (MI) contact center. Attendees will learn how to ensure local market buy-in, achieve complete market coverage, and measure customer satisfaction to ensure the health and safety of patients.
May 22, 2025
Under EMA Policy 0070, sponsors are mandated to submit anonymized clinical reports for publication on the Clinical Data Publication (CDP) portal, where they can be accessed by external researchers. Discover best practices for meeting EMA Policy 0070 requirements efficiently and effectively
April 29, 2025
Unpack the latest regulatory trends, FDA expectations, and compliance strategies for medical device software, IVDs, and AI-driven technologies—gain real-world insights to accelerate development and de-risk your path to market.
April 10, 2025
We’ll dive into how AI can reduce errors, save time, and enhance accuracy in listings and summary tabulations. But what about the challenges? From software costs to data security risks and programming limitations, we’ll address the key considerations for implementing AI in PV.
November 19, 2024
Discover strategies to transition Phase III clinical trial patients to commercial products, while ensuring accessibility, affordability, and compliance.
October 22, 2024
Learn strategies for assessing and filing post-approval changes in small molecule products while ensuring regulatory compliance.
June 20, 2024
An essential guide to PV system implementation in the UK and EU/EEA.
April 24, 2024
Learn to identify and mitigate risks in vendor relationships with confidence.
April 18, 2024
Leveraging AI to de-risk Pharmaceutical, Biotech, and Medical Device programs and maximize success. Learn how generative AI applied to massive data can optimize product development end-to-end.
December 06, 2023
An in-depth webinar exploring how to confidently navigate the complex regulatory landscape for Software as a Medical Device (SaMD) and Software in a Medical Device (SiMD).
September 28, 2023
Gain insights on the current opportunities that can simplify the path to ATMP development including, decentralised manufacturing, utilizing the hospital exemption in the EU, early integration of devices and diagnostics into the overall development plan, and addressing the growing demand for comparative results from stakeholders in drug development.
September 20, 2023
How life science companies can realize the full value of their R&D data.
July 11, 2023
Navigating regulatory challenges, optimizing protocols and breaking access barriers.
April 18, 2023
Learn how to showcase your product in the best scientific light, optimize statistical processes, animal models, and pharmacodynamics for better results.